English version of this page

Publikasjoner 2014

Listen inneholder publikasjoner fra Klinisk Effektforskningsgruppen ved Avdeling for Helseledelse og Helseøkonomi. I 2014 ble det utgitt 19 publikasjoner og kommentarer i fagfellevurderte tidsskrifter og 3 populærvitenskapelige artikler i massemedia. 2 artikler (11%) ble publisert i gruppe 2a tidsskrifter (New England Journal og JAMA) og 9 (47%) i gruppe 2 tidsskrifter. Akkumulert impact faktor for gruppens artikler i 2014 er 148.

Publikasjonsliste

Originalartikler:

1: Garborg K, Kaminski MF, Lindenburger W, Wiig H, Hasund A, Wronska E, Bie RB,

Kleist B, Løvdal L, Holme O, Kalager M, Hoff G, Bretthauer M. Water exchange

versus carbon dioxide insufflation in unsedated colonoscopy: a multicenter

randomized controlled trial. Endoscopy. 2014 Nov 20. PubMed PMID: 25412093.

Impact factor: 5.196

 

2: Holme O, Bretthauer M, Eide TJ, Løberg EM, Grzyb K, Løberg M, Kalager M, Adami

HO, Kjellevold O, Hoff G. Long-term risk of colorectal cancer in individuals with

serrated polyps. Gut. 2014 Nov 16. pii: gutjnl-2014-307793. PubMed PMID: 25399542

Impact factor: 13.319

 

3: Spada C, Stoker J, Alarcon O, Barbaro F, Bellini D, Bretthauer M, De Haan MC,

Dumonceau JM, Ferlitsch M, Halligan S, Helbren E, Hellstrom M, Kuipers EJ, Lefere

P, Mang T, Neri E, Petruzziello L, Plumb A, Regge D, Taylor SA, Hassan C, Laghi

A. Clinical indications for computed tomographic colonography: European Society

of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and

Abdominal Radiology (ESGAR) Guideline. Eur Radiol. 2014 Oct 3. PMID: 25278245.

Impact factor: 4.338

 

4: Spada C, Stoker J, Alarcon O, Barbaro F, Bellini D, Bretthauer M, De Haan MC,

Dumonceau JM, Ferlitsch M, Halligan S, Helbren E, Hellstrom M, Kuipers EJ, Lefere

P, Mang T, Neri E, Petruzziello L, Plumb A, Regge D, Taylor SA, Hassan C, Laghi

A. Clinical indications for computed tomographic colonography: European Society

of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and

Abdominal Radiology (ESGAR) Guideline. Endoscopy. 2014;46:897-915. PubMed PMID:

25268304. Impact factor: 5.196

 

5: Berstad P, Løberg M, Larsen IK, Kalager M, Holme O, Botteri E, Bretthauer M,

Hoff G. Long-term lifestyle changes after colorectal cancer screening: randomised

controlled trial. Gut. 2014 i: gutjnl-2014-307376. PubMed PMID: 25183203.

Impact factor: 13.319

 

6: Løberg M, Kalager M, Holme Ø, Hoff G, Adami HO, Bretthauer M. Long-term

colorectal-cancer mortality after adenoma removal. N Engl J Med. 2014;371:799-807.

PubMed PMID: 25162886. Impact factor: 54.42

 

7: Holme Ø, Løberg M, Kalager M, Bretthauer M, Hernán MA, Aas E, Eide TJ,

Skovlund E, Schneede J, Tveit KM, Hoff G. Effect of flexible sigmoidoscopy

screening on colorectal cancer incidence and mortality: a randomized clinical

trial. JAMA. 2014;312:606-15. PubMed PMID: 25117129. Impact factor: 30

 

8: Kalager M, Løberg M, Bretthauer M, Adami HO. Comparative analysis of breast

cancer mortality following mammography screening in Denmark and Norway. Ann

Oncol. 2014;25:1137-43. PubMed PMID: 24669012. Impact factor: 6.578

 

Reviews/oversiktsartikler:

9: van Dam L, Bretthauer M. Ethical issues in colorectal cancer screening. Best

Pract Res Clin Gastroenterol. 2014;28:315-26. PubMed PMID: 24810192.

Impact factor: 3.277

 

10: Hassan C, Gimeno-García A, Kalager M, Spada C, Zullo A, Costamagna G, Senore

C, Rex DK, Quintero E. Systematic review with meta-analysis: the incidence of

advanced neoplasia after polypectomy in patients with and without low-risk

adenomas. Aliment Pharmacol Ther. 2014;39:905-12. PubMed PMID: 24593121.

Impact factor: 5.478

 

11. Løberg M, Lousdal ML, Bretthauer M, Kalager M. Review: Benefits and

harms of mammography screening. Breast Cancer Res, in press sept 2014

Impact factor: 5.881

 

Editorials/kommentarer:

12: Jodal HC, Reyes YD, Roksund G, Bretthauer M. Implementering av retningslinjer

for PSA-testing i allmennpraksis. Tidsskr Nor Laegeforen. 2014;134:2032-4. Article in

Norwegian. PubMed PMID: 25387926.

 

13: Kalager M. Overdiagnosis in breast cancer screening: women have minimal prior

awareness of the issue, and their screening intentions are influenced by the size

of the risk. Evid Based Nurs. 2014;17:7-8. PubMed PMID: 24001593.

 

14: Bretthauer M, Brandrud AS. Endoscopy training: time to stop counting

procedures? Gut. 2014;63:1686-7. PubMed PMID: 24604824.

 

15: Hem E, Gjersvik P, Bretthauer M. [Comparative effectiveness research]. Tidsskr

Nor Laegeforen. 2014;134:1374. PubMed PMID: 25096435.

 

16: Gjersvik P, Hem E, Jacobsen GW, Bretthauer M. [P. Gjersvik and colleagues

reply]. Tidsskr Nor Laegeforen. 2014;134:1215. PubMed PMID: 24989185.

 

17: Gjersvik P, Hem E, Jacobsen GW, Bretthauer M. [What should non-inferiority

studies be called in Norwegian?]. Tidsskr Nor Laegeforen. 2014;134:852-3. PubMed PMID: 24780988.

 

18: Kalager M, Adami HO, Bretthauer M. Too much mammography. BMJ. 2014 Feb

11;348:g1403. PubMed PMID: 24519765.

 

19: Hoff G, Bretthauer M, Garborg K, Eide TJ. [Consensus-based guidelines may

prevent necessary research]. Tidsskr Nor Laegeforen. 2014;134:148-9.

PubMed PMID: 24477144.

 

Populærvitenskapelige artikler:

Kalager M, Bretthauer M. Bartens dårlige venner. Dagbladet 03.11.2014.

Bretthauer M. Kronikk: Nei, screening redder ikke liv. Aftenposten 27.08.2014

Roksund G, Bretthauer M, Kalager M. En epidemi av diagnoser, ikke sykdom. Aftenposten 27.05.2014

 

Publisert 16. des. 2014 11:06 - Sist endret 27. jan. 2015 13:28